ZZZhi-Sen Zhou

Zhi-Sen Zhou

*This is an algorithmically generated author record based on publicly available information.

Zhi-Sen Zhou has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Genlong Jiao

    Dongguan Key Laboratory of Central Nervous System Injury and Repair/Dongguan Institute of Spine and Spinal Cord Injury, The Sixth Affiliated Hospital of Jinan University (Dongguan), Dongguan, 523573, China

    2 shared publications
  • Fan-Wen Teng

    Dongguan Key Laboratory of Central Nervous System Injury and Repair/Dongguan Institute of Spine and Spinal Cord Injury, The Sixth Affiliated Hospital of Jinan University (Dongguan), Dongguan, 523573, China

    1 shared publication
  • Fuxin Wei

    Department of Orthopaedics, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China

    1 shared publication
  • Guan-Hai Wang

    The First Dongguan Affiliated Hospital, School of Pharmacy, Guangdong Medical University, Dongguan 523808, China

    1 shared publication
  • Guoliang Chen

    Department of Orthopedic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, China

    1 shared publication
  • Haoran Zhu

    Department of Orthopedic Surgery, The Fifth Affiliated Hospital of Jinan University (Heyuan Shenhe People's Hospital), Heyuan, 517400, China

    1 shared publication

Latest Publications

  • Open Access

    Copper peptide activated cascade catalysis for glucose regulation and hypoxia reversing in infected diabetic wound healing

    by Zeng-Jin Huang, Rui-Feng Huang, Ping-Ping Jiao, Shuai Zheng, Meng Wang, Fan-Wen Teng, Tuo Chen, Zhi-Sen Zhou, Guan-Hai Wang, Gen-Long Jiao


  • Open Access

    Extracellular vesicles released by transforming growth factor-beta 1-preconditional mesenchymal stem cells promote recovery in mice with spinal cord injury

    by Guoliang Chen, Kuileung Tong, Shiming Li, Zerong Huang, Shuangjiang Liu, Haoran Zhu, Yanheng Zhong, Zhisen Zhou, Genlong Jiao, Fuxin Wei, et al.

    Spinal cord injury (SCI) causes neuroinflammation, neuronal death, and severe axonal connections. Alleviating neuroinflammation, protecting residual cells and promoting neuronal regeneration via endogenous neural stem cells (eNSCs) represent potential strategies for SCI treatment. Extracellular vesicles (EVs) released by mesenchymal stem cells have emerged as pathological mediators and alternatives to cell-based therapies following SCI. In the present study, EVs isolated from untreated (control, C-EVs) and TGF-β1-treated (T-EVs) mesenchymal stem cells were injected into SCI mice to compare the therapeutic effects and explore the underlying mechanisms. Our study demonstrated for the first time that the application of T-EVs markedly enhanced the proliferation and antiapoptotic ability of NSCs in vitro. The infusion of T-EVs into SCI mice increased the shift from the M1 to M2 polarization of reactive microglia, alleviated neuroinflammation, and enhanced the neuroprotection of residual cells during the acute phase. Moreover, T-EVs increased the number of eNSCs around the epicenter. Consequently, T-EVs further promoted neurite outgrowth, increased axonal regrowth and remyelination, and facilitated locomotor recovery in the chronic stage. Furthermore, the use of T-EVs in Rictor−/− SCI mice (conditional knockout of Rictor in NSCs) showed that T-EVs failed to increase the activation of eNSCs and improve neurogenesis sufficiently, which suggested that T-EVs might induce the activation of eNSCs by targeting the mTORC2/Rictor pathway. Taken together, our findings indicate the prominent role of T-EVs in the treatment of SCI, and the therapeutic efficacy of T-EVs for SCI treatment might be optimized by enhancing the activation of eNSCs via the mTORC2/Rictor signaling pathway.